Document Detail

Long-chain polyunsaturated fatty acids and neurological developmental outcome at 18 months in healthy term infants.
MedLine Citation:
PMID:  15858956     Owner:  NLM     Status:  MEDLINE    
AIM: Previously, we found a beneficial effect of 2 mo supplementation of infant formula with long-chain polyunsaturated fatty acids (LC-PUFA) on neurological condition at 3 mo in healthy term infants. The aim of the present follow-up study was to evaluate whether the effect on neurological condition persists until 18 mo. METHODS: A prospective, double-blind, randomized control study was conducted. Three groups were formed: a control (CF; n = 169), an LC-PUFA-supplemented (LF; n = 146) and a breastfed (BF; n = 159) group. Information on potential confounders was collected at enrolment. At the age of 18 mo, neurodevelopmental condition was assessed by the age-specific neurological examination of Hempel and the Bayley scales. The Hempel assessment resulted in a clinical neurological diagnosis, a total optimality score and a score on the fluency of motility. The Bayley scales resulted in mental and psychomotor developmental indices. Attrition at 18 mo was 5.5% and non-selective. Multivariate regression analyses were carried out to evaluate the effect of type of feeding while adjusting for confounders. RESULTS: None of the children had developed cerebral palsy and 23 (CF: n = 8; LF: n = 10; BF: n = 5) showed minor neurological dysfunction. The groups did not show statistically significant differences in clinical neurological condition, neurological optimality score, fluency score, and the psychomotor and mental development indices. Multivariate analysis confirmed that there was no effect of type of feeding on neurological condition. CONCLUSION: This study indicates that the beneficial neurodevelopmental effect of 2 mo LC-PUFA supplementation in healthy term infants can not be detected at the age of 18 mo.
H Bouwstra; D A J Dijck-Brouwer; G Boehm; E R Boersma; F A J Muskiet; M Hadders-Algra
Related Documents :
16967366 - Sequential neurological examinations in infants with neonatal encephalopathy and low ap...
22833586 - Schore's regulation theory: maternal-infant interaction in the nicu as a mechanism for ...
12108076 - Hypoxic-ischemic encephalopathy: pathophysiology and implications for therapy.
22706996 - Infant mortality among arab-americans: findings from the arab-american birth outcomes s...
22123886 - Symptomatic neonatal arterial ischemic stroke: the international pediatric stroke study.
19857146 - Lack of effect on prematurity, birth weight, and infant growth from exposure to proteas...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta paediatrica (Oslo, Norway : 1992)     Volume:  94     ISSN:  0803-5253     ISO Abbreviation:  Acta Paediatr.     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2005-04-29     Completed Date:  2005-06-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9205968     Medline TA:  Acta Paediatr     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  26-32     Citation Subset:  IM    
Department of Neurology, University of Groningen, Groningen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Factors
Breast Feeding
Child Development / drug effects*
Dietary Supplements*
Double-Blind Method
Drug Administration Schedule
Fatty Acids, Unsaturated / administration & dosage*
Follow-Up Studies
Infant Formula*
Mental Processes / drug effects*
Prospective Studies
Psychomotor Performance / drug effects*
Reg. No./Substance:
0/Fatty Acids, Unsaturated

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Is screening ultrasound of the urinary tract indicated in infants with hypertrophic pyloric stenosis...
Next Document:  Carotid artery intima-media thickness and angiotensin-converting enzyme gene polymorphism in the off...